148 related articles for article (PubMed ID: 30927976)
1. Therapy-related myeloid neoplasms after treatment for plasma-cell disorders.
Chung A; Liedtke M
Best Pract Res Clin Haematol; 2019 Mar; 32(1):54-64. PubMed ID: 30927976
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic Features of Therapy-Related Myeloid Neoplasms in Patients with Myeloma in the Era of Novel Therapies.
Jelloul FZ; Quesada AE; Yang RK; Li S; Wang W; Xu J; Tang G; Yin CC; Fang H; El Hussein S; Khoury J; Bassett RL; Garcia-Manero G; Manasanch EE; Orlowski RZ; Qazilbash MH; Patel KP; Medeiros LJ; Lin P
Mod Pathol; 2023 Jun; 36(6):100166. PubMed ID: 36990279
[TBL] [Abstract][Full Text] [Related]
3. Diagnosing therapy-related acute myeloid leukemia with 8% blasts in bone marrow with concomitant plasma cell myeloma.
Thakral B; Muzzafar T
Blood; 2017 Jul; 130(2):231. PubMed ID: 28705862
[No Abstract] [Full Text] [Related]
4. Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma.
Jonsdottir G; Björkholm M; Turesson I; Hultcrantz M; Diamond B; Porwit A; Landgren O; Kristinsson SY
Eur J Haematol; 2021 Aug; 107(2):275-282. PubMed ID: 33966293
[TBL] [Abstract][Full Text] [Related]
5. Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS).
Mailankody S; Pfeiffer RM; Kristinsson SY; Korde N; Bjorkholm M; Goldin LR; Turesson I; Landgren O
Blood; 2011 Oct; 118(15):4086-92. PubMed ID: 21795746
[TBL] [Abstract][Full Text] [Related]
6. Can allogeneic hematopoietic cell transplant cure therapy-related acute leukemia?
Madanat YF; Gerds AT
Best Pract Res Clin Haematol; 2019 Mar; 32(1):104-113. PubMed ID: 30927969
[TBL] [Abstract][Full Text] [Related]
7. Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? A clinicopathologic study of 41 cases and correlation of cytogenetic features with treatment regimens.
Reddi DM; Lu CM; Fedoriw G; Liu YC; Wang FF; Ely S; Boswell EL; Louissaint A; Arcasoy MO; Goodman BK; Wang E
Am J Clin Pathol; 2012 Dec; 138(6):855-66. PubMed ID: 23161720
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and outcomes of patients with multiple myeloma who develop therapy-related myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia.
Pemmaraju N; Shah D; Kantarjian H; Orlowski RZ; Nogueras González GM; Baladandayuthapani V; Jain N; Wagner V; Garcia-Manero G; Shah J; Ravandi F; Pierce S; Takahashi K; Daver N; Nazha A; Verstovsek S; Jabbour E; De Lima M; Champlin R; Cortes J; Qazilbash MH
Clin Lymphoma Myeloma Leuk; 2015 Feb; 15(2):110-4. PubMed ID: 25107338
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological aspects of therapy-related acute myeloid leukemia and myelodysplastic syndrome.
Chua CC; Fleming S; Wei AH
Best Pract Res Clin Haematol; 2019 Mar; 32(1):3-12. PubMed ID: 30927972
[TBL] [Abstract][Full Text] [Related]
10. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
[TBL] [Abstract][Full Text] [Related]
11. AML transformation after autologous stem cell transplant for multiple myeloma.
Gupta SK; Chandramohan J; Kumar L
BMJ Case Rep; 2015 May; 2015():. PubMed ID: 26025976
[TBL] [Abstract][Full Text] [Related]
12. Clonal Hematopoiesis and therapy related MDS/AML.
Desai P; Roboz GJ
Best Pract Res Clin Haematol; 2019 Mar; 32(1):13-23. PubMed ID: 30927970
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and outcomes of therapy-related myeloid neoplasms after treatment for multiple myeloma.
Duong VH; Holtzman NG; Koka R; Singh ZN; Zou Y; Emadi A; Rapoport AP; Kocoglu MH; Baer MR; Badros AZ
Leuk Lymphoma; 2019 Dec; 60(14):3577-3580. PubMed ID: 31282234
[No Abstract] [Full Text] [Related]
14. The emerging importance and evolving understanding of clonal hematopoiesis in multiple myeloma.
DeStefano CB; Gibson SJ; Sperling AS; Richardson PG; Ghobrial I; Mo CC
Semin Oncol; 2022 Feb; 49(1):19-26. PubMed ID: 35105451
[TBL] [Abstract][Full Text] [Related]
15. Therapy-related myeloid neoplasms: pathobiology and clinical characteristics.
Sill H; Olipitz W; Zebisch A; Schulz E; Wölfler A
Br J Pharmacol; 2011 Feb; 162(4):792-805. PubMed ID: 21039422
[TBL] [Abstract][Full Text] [Related]
16. Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation.
Lim ZY; Fiaccadori V; Gandhi S; Hayden J; Kenyon M; Ireland R; Marsh J; Ho AY; Mufti GJ; Pagliuca A
Leuk Res; 2010 Jun; 34(6):723-7. PubMed ID: 19944463
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of 220 mg/m2 melphalan followed by autologous stem cell transplantation in patients with advanced haematological malignancies: pharmacokinetics and toxicity.
Moreau P; Kergueris MF; Milpied N; Le Tortorec S; Mahé B; Bulabois CE; Rapp MJ; Larousse C; Bataille R; Harousseau JL
Br J Haematol; 1996 Dec; 95(3):527-30. PubMed ID: 8943896
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic hematopoietic stem cell transplantation: an option for long-term survival for patients with simultaneous appearance of myeloid and lymphatic malignancies.
Weber T; Ocheni S; Binder M; Theurich S; Scheid C; Schmid C; Müller LP; Christopeit M; Bacher U
Acta Haematol; 2013; 129(3):135-6. PubMed ID: 23207834
[No Abstract] [Full Text] [Related]
19. Myeloid disorders after autoimmune disease.
Boddu PC; Zeidan AM
Best Pract Res Clin Haematol; 2019 Mar; 32(1):74-88. PubMed ID: 30927978
[TBL] [Abstract][Full Text] [Related]
20. Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML.
Nevill TJ; Hogge DE; Toze CL; Nantel SH; Power MM; Abou Mourad YR; Song KW; Lavoie JC; Forrest DL; Barnett MJ; Shepherd JD; Nitta JY; Wong S; Sutherland HJ; Smith CA
Bone Marrow Transplant; 2008 Nov; 42(10):659-66. PubMed ID: 18679372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
